ANI Pharmaceuticals Inc (ANIP) stock
ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 14/3048% below fair value
$69.99−0.90 (-1.27%)
Close on Nov 17, 2026Market cap $1.61BP/E 14.9Yield –
ANI Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
ANI Pharmaceuticals's total assets was $1.49B at Jun 30, 2026. For fiscal 2025 it was $1.44B, up 12.1% from the year before. Over ten years it grew 17.6% a year on average. The highest annual figure on record is $1.44B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44B | +12.1% |
| FY2024 | Dec 31, 2024 | $1.28B | +42.0% |
| FY2023 | Dec 31, 2023 | $904.42M | +19.0% |
| FY2022 | Dec 31, 2022 | $760.09M | -1.5% |
| FY2021 | Dec 31, 2021 | $771.60M | +67.3% |
| FY2020 | Dec 31, 2020 | $461.19M | +1.0% |
| FY2019 | Dec 31, 2019 | $456.79M | +6.1% |
| FY2018 | Dec 31, 2018 | $430.60M | +4.5% |
| FY2017 | Dec 31, 2017 | $412.14M | +27.7% |
| FY2016 | Dec 31, 2016 | $322.86M | +13.2% |
| FY2015 | Dec 31, 2015 | $285.27M | +9.9% |
| FY2014 | Dec 31, 2014 | $259.56M | +483.3% |
| FY2013 | Dec 31, 2013 | $44.50M | +223.7% |
| FY2012 | Dec 31, 2012 | $13.75M | -78.0% |
| FY2011 | Dec 31, 2011 | $62.38M | +39.3% |
| FY2010 | Dec 31, 2010 | $44.77M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.49B | +11.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.42B | +10.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.44B | +12.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.41B | +9.4% |
| Q2 FY2025 | Jun 30, 2025 | $1.34B | +45.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.29B | +41.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.28B | +42.0% |
| Q3 FY2024 | Sep 30, 2024 | $1.29B | +44.7% |
| Q2 FY2024 | Jun 30, 2024 | $920.75M | +7.1% |
| Q1 FY2024 | Mar 31, 2024 | $914.52M | +19.5% |
| Q4 FY2023 | Dec 31, 2023 | $904.42M | +19.0% |
| Q3 FY2023 | Sep 30, 2023 | $889.91M | +20.4% |
| Q2 FY2023 | Jun 30, 2023 | $859.34M | +14.4% |
| Q1 FY2023 | Mar 31, 2023 | $765.22M | +2.7% |
| Q4 FY2022 | Dec 31, 2022 | $760.09M | -1.5% |
| Q3 FY2022 | Sep 30, 2022 | $739.11M | +57.1% |
| Q2 FY2022 | Jun 30, 2022 | $751.33M | +56.5% |
| Q1 FY2022 | Mar 31, 2022 | $744.85M | +60.6% |
| Q4 FY2021 | Dec 31, 2021 | $771.60M | +67.3% |
| Q3 FY2021 | Sep 30, 2021 | $470.45M | +1.7% |
| Q2 FY2021 | Jun 30, 2021 | $480.16M | +3.2% |
| Q1 FY2021 | Mar 31, 2021 | $463.84M | -3.8% |
| Q4 FY2020 | Dec 31, 2020 | $461.19M | +1.0% |
| Q3 FY2020 | Sep 30, 2020 | $462.58M | +1.3% |
| Q2 FY2020 | Jun 30, 2020 | $465.39M | +4.1% |
| Q1 FY2020 | Mar 31, 2020 | $482.23M | +11.0% |
| Q4 FY2019 | Dec 31, 2019 | $456.79M | +6.1% |
| Q3 FY2019 | Sep 30, 2019 | $456.78M | +3.9% |
| Q2 FY2019 | Jun 30, 2019 | $446.91M | +5.4% |
| Q1 FY2019 | Mar 31, 2019 | $434.39M | +3.9% |
| Q4 FY2018 | Dec 31, 2018 | $430.60M | +4.5% |
| Q3 FY2018 | Sep 30, 2018 | $439.44M | +18.6% |
| Q2 FY2018 | Jun 30, 2018 | $424.18M | +18.1% |
| Q1 FY2018 | Mar 31, 2018 | $418.02M | +17.0% |
| Q4 FY2017 | Dec 31, 2017 | $412.14M | +27.7% |
| Q3 FY2017 | Sep 30, 2017 | $370.47M | +16.0% |
| Q2 FY2017 | Jun 30, 2017 | $359.22M | – |
| Q1 FY2017 | Mar 31, 2017 | $357.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $322.86M | – |
| Q3 FY2016 | Sep 30, 2016 | $319.38M | – |
See a number that looks wrong?